M Malavolti

455 total citations
21 papers, 359 citations indexed

About

M Malavolti is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, M Malavolti has authored 21 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in M Malavolti's work include Drug Transport and Resistance Mechanisms (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). M Malavolti is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). M Malavolti collaborates with scholars based in United States, Italy and United Kingdom. M Malavolti's co-authors include Hans Fromm, Susan Ceryak, I Roberts, E. Roda, Bernard Bouscarel, Franco Bazzoli, L. Barbara, Claudia Sama, Antonio Maria Morselli‐Labate and Luigi Barbara and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

M Malavolti

20 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Malavolti United States	11	175	136	118	82	62	21	359
I. Lorenzini Italy	8	136 0.8×	111 0.8×	81 0.7×	36 0.4×	40 0.6×	22	293
Rajendra P. Sarva United States	10	260 1.5×	202 1.5×	113 1.0×	70 0.9×	200 3.2×	11	542
Lee Sd Taiwan	11	135 0.8×	40 0.3×	143 1.2×	47 0.6×	58 0.9×	53	361
Rossella Iori Italy	11	287 1.6×	266 2.0×	145 1.2×	20 0.2×	89 1.4×	14	476
Hofmann Af United States	12	282 1.6×	368 2.7×	121 1.0×	53 0.6×	180 2.9×	25	647
I.A.D. Bouchier United Kingdom	9	207 1.2×	106 0.8×	73 0.6×	45 0.5×	50 0.8×	18	356
John P. Kirchner United States	8	79 0.5×	64 0.5×	98 0.8×	17 0.2×	49 0.8×	12	295
Alejandro Raddatz Chile	10	356 2.0×	67 0.5×	153 1.3×	45 0.5×	142 2.3×	14	536
B. G. Petersson Sweden	12	223 1.3×	167 1.2×	85 0.7×	31 0.4×	34 0.5×	18	453
Hugh J. Kennedy United Kingdom	6	117 0.7×	83 0.6×	228 1.9×	39 0.5×	23 0.4×	9	376

Countries citing papers authored by M Malavolti

Since Specialization

Citations

This map shows the geographic impact of M Malavolti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Malavolti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Malavolti more than expected).

Fields of papers citing papers by M Malavolti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Malavolti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Malavolti. The network helps show where M Malavolti may publish in the future.

Co-authorship network of co-authors of M Malavolti

This figure shows the co-authorship network connecting the top 25 collaborators of M Malavolti. A scholar is included among the top collaborators of M Malavolti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Malavolti. M Malavolti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ceryak, Susan, et al.. (2000). Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters. Atherosclerosis. 153(1). 59–67. 5 indexed citations

Malavolti, M, et al.. (1999). Effect of Ursodeoxycholic Acid Administration in Patients with Primary Hypercholesterolaemia. Clinical Drug Investigation. 18(4). 263–269. 2 indexed citations

Ceryak, Susan, Bernard Bouscarel, M Malavolti, & Hans Fromm. (1998). Extrahepatic deposition and cytotoxicity of lithocholic acid: Studies in two hamster models of hepatic failure and in cultured human fibroblasts. Hepatology. 27(2). 546–556. 26 indexed citations

Sama, C, et al.. (1998). Ursodeoxycholic acid in liver transplantation: Effect on cholestasis and rejection. Gastroenterology. 114. A1332–A1332. 1 indexed citations

Sama, Claudia, et al.. (1997). Effect of Ursodeoxycholic Acid on Liver Tests in Chronic Hepatitis. Clinical Drug Investigation. 13(4). 192–198. 5 indexed citations

Malavolti, M, et al.. (1996). Flutamide-induced toxic hepatitis. Digestive Diseases and Sciences. 41(11). 2219–2221. 16 indexed citations

Zamboni, Lorenzo, et al.. (1995). Ursodeoxycholic acid in the management of primary constipation: A cross-over study. Gastroenterology. 108(4). A1207–A1207. 1 indexed citations

Malavolti, M, et al.. (1993). Formation, absorption, and biotransformation of delta 6-lithocholenic acid in humans. American Journal of Physiology-Gastrointestinal and Liver Physiology. 264(1). G163–G171. 15 indexed citations

Fromm, Hans & M Malavolti. (1992). Bile acid dissolution therapy of gallbladder stones. Baillière s Clinical Gastroenterology. 6(4). 689–695. 6 indexed citations

10.

Malavolti, M, et al.. (1991). Cerebral low-density lipoprotein (LDL) uptake is stimulated by acute bile drainage. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1081(1). 106–108. 16 indexed citations

11.

Malavolti, M, et al.. (1990). Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster. Life Sciences. 46(23). 1727–1737. 2 indexed citations

12.

Malavolti, M, et al.. (1989). Interaction of potentially toxic bile acids with human plasma proteins: Binding of lithocholic (3α‐hydroxy‐5β‐cholan‐24‐oic) acid to lipoproteins and albumin. Lipids. 24(7). 673–676. 9 indexed citations

13.

Malavolti, M, Susan Ceryak, & Hans Fromm. (1987). Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster. Gastroenterology. 93(5). 1104–1115. 14 indexed citations

14.

Fromm, Hans, et al.. (1987). Absence of significant role of bile acids in diarrhea of a heterogeneous group of postcholecystectomy patients. Digestive Diseases and Sciences. 32(1). 33–44. 23 indexed citations

15.

Barbara, L, G. Mazzella, M. Baraldini, et al.. (1986). A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Journal of Hepatology. 3. S235–S238. 13 indexed citations

16.

Fromm, Hans, et al.. (1986). Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Digestive Diseases and Sciences. 31(10). 1032–1040. 37 indexed citations

17.

Malavolti, M, Susan Ceryak, & Hans Fromm. (1986). Modulation of bile flow and of biliary bile acid and cholesterol excretion by hepatic low density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster. 2. 1744. 1 indexed citations

18.

Fromm, Hans & M Malavolti. (1986). Bile Acid-Induced Diarrhoea. Clinics in Gastroenterology. 15(3). 567–582. 91 indexed citations

19.

Malavolti, M, Hans Fromm, Brian D. Cohen, & Susan Ceryak. (1985). Isolation and identification of delta 6-lithocholenic acid (3 alpha-hydroxy-5 beta-6-cholen-24-oic acid) as an intestinal bacterial metabolite of chenodeoxycholic acid in man.. Journal of Biological Chemistry. 260(20). 11011–11015. 8 indexed citations

20.

Bazzoli, Franco, et al.. (1983). Treatment of Constipation with Chenodeoxycholic Acid. Journal of International Medical Research. 11(2). 120–123. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact